Geron reported $28.8M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amgen AMGN:US $ 3.74B 804M
Bio Techne TECH:US $ 199.93M 7M
Cti Biopharma CTIC:US $ 37.39M 2.02M
Cytokinetics CYTK:US $ 81.7M 4.39M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Exelixis EXEL:US $ 272.74M 61.76M
Genmab GEN:DC 1.61B 205M
Geron GERN:US $ 28.8M 3.22M
Gilead Sciences GILD:US $ 6393M 89M
Macrogenics MGNX:US $ 77.74M 5.36M
Novartis NOVN:VX 9.96B 998M
Novavax NVAX:US $ 494.68M 552.49M
Pain Therapeutics PTIE:US $ 17.82M 3.38M
Seattle Genetics SGEN:US $ 559.51M 42.41M
YTE INCY:US $ 616.69M 135.42M